BlackRock Health Sciences Trust (NYSE:BME) Share Price Crosses Above 50 Day Moving Average – Time to Sell?
by Teresa Graham · The Cerbat GemBlackRock Health Sciences Trust (NYSE:BME – Get Free Report)’s share price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $39.22 and traded as high as $39.96. BlackRock Health Sciences Trust shares last traded at $39.3350, with a volume of 67,527 shares changing hands.
BlackRock Health Sciences Trust Price Performance
The firm’s fifty day moving average price is $39.22 and its 200-day moving average price is $40.56.
Hedge Funds Weigh In On BlackRock Health Sciences Trust
A number of hedge funds have recently modified their holdings of BME. Royal Bank of Canada grew its position in shares of BlackRock Health Sciences Trust by 0.5% during the first quarter. Royal Bank of Canada now owns 143,546 shares of the company’s stock worth $5,546,000 after acquiring an additional 684 shares during the last quarter. Jones Financial Companies Lllp purchased a new position in shares of BlackRock Health Sciences Trust during the first quarter worth approximately $386,000. Invesco Ltd. grew its position in shares of BlackRock Health Sciences Trust by 0.5% during the second quarter. Invesco Ltd. now owns 201,788 shares of the company’s stock worth $7,357,000 after acquiring an additional 1,047 shares during the last quarter. First Trust Advisors LP grew its position in shares of BlackRock Health Sciences Trust by 108.1% during the second quarter. First Trust Advisors LP now owns 14,930 shares of the company’s stock worth $544,000 after acquiring an additional 7,754 shares during the last quarter. Finally, NewEdge Advisors LLC grew its position in shares of BlackRock Health Sciences Trust by 8.5% during the second quarter. NewEdge Advisors LLC now owns 14,185 shares of the company’s stock worth $517,000 after acquiring an additional 1,111 shares during the last quarter.
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.